Nicolex (Nicotine)

Nicotine, the active ingredient in Nicolex, is a nicotinic receptor agonist presented as an oromucosal formulation for oral mucosal use. It is employed to reduce nicotine withdrawal symptoms and support smoking cessation in adult smokers. GNH USA supplies Nicolex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicolex is a nicotinic receptor agonist used in the management of nicotine dependence and related conditions. - Smoking cessation: helps adult smokers reduce withdrawal symptoms and quit tobacco use. - Nicotine dependence: alleviates cravings during cessation attempts. - Relapse prevention: assists former smokers in maintaining abstinence from tobacco.

Side effects of oromucosal nicotine products vary in frequency and severity.

Common Side Effects: - Mouth irritation or soreness: discomfort at the site of application. - Nausea or upset stomach: mild gastrointestinal upset after use. - Dizziness or light‑headedness: transient sensation of unsteadiness. - Headache: mild to moderate pain in the head region. - Increased salivation: excess saliva production in the mouth.

Serious or Rare Side Effects: - Cardiovascular events: elevated blood pressure, palpitations, or arrhythmias. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe oral ulceration: painful sores that persist beyond normal irritation. - Seizures: rare occurrence, typically in cases of overdose.

Before initiating Nicolex, certain safety considerations should be observed. - Assess cardiovascular status: evaluate for hypertension or recent cardiac events. - Avoid in recent myocardial infarction: contraindicated in patients with recent heart attacks. - Monitor for nicotine toxicity: watch for signs of overuse such as vomiting or rapid heartbeat. - Use caution in pregnancy: discuss potential risks with a healthcare provider. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - CYP2A6 inhibitors: can raise nicotine plasma concentrations. - Concurrent nicotine products: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may enhance nausea. - Antihypertensive agents: nicotine can reduce their efficacy. - Alcohol: may increase nicotine cravings and affect metabolism.